Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
160.00
+10.50 (7.02%)
At close: Feb 11, 2026

TPE:6919 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
3,0026,9013,422655.05594.9193.56
Short-Term Investments
3,5152,767289.4456.18--
Cash & Short-Term Investments
6,5179,6693,7121,111594.9193.56
Cash Growth
-32.78%160.51%234.01%86.79%535.87%331.36%
Accounts Receivable
2.895.187.893.12--
Receivables
2.895.187.893.12--
Inventory
5.072.861.022.810.052.53
Other Current Assets
87.4929.1223.1614.8710.3214.96
Total Current Assets
6,6129,7063,7441,132605.27111.05
Property, Plant & Equipment
53.1761.3280.4199.6106.38114.68
Other Intangible Assets
-----0.07
Other Long-Term Assets
7.73.142.461.461.261.26
Total Assets
9,4559,7713,8271,233712.9227.05
Accounts Payable
1.110.971.72.530.330.74
Accrued Expenses
2.531.97--30.9845.14
Current Portion of Long-Term Debt
----1.177.97
Current Portion of Leases
5.238.888.588.227.036.79
Current Unearned Revenue
6.243.611.034.5--
Other Current Liabilities
42.737.3262.3733.110.163.82
Total Current Liabilities
57.852.7473.6848.3639.6764.45
Long-Term Debt
----3.5583.95
Long-Term Leases
-311.8720.4625.0232.06
Pension & Post-Retirement Benefits
0.310.24----
Other Long-Term Liabilities
20.2117.71----
Total Liabilities
78.3273.785.5568.8268.24180.46
Common Stock
775.45769.14696.62615.55535.93312.17
Additional Paid-In Capital
8,7499,1313,271834.46217.47106.85
Retained Earnings
-7.73-56.14-227.31-286.16-107.41-371.05
Treasury Stock
---0.07-0.08-0.09-
Comprehensive Income & Other
-139.45-147.470.810.49-1.24-1.38
Shareholders' Equity
9,3779,6973,7411,164644.6646.6
Total Liabilities & Equity
9,4559,7713,8271,233712.9227.05
Total Debt
5.2311.8720.4628.6836.78130.76
Net Cash (Debt)
6,5119,6573,6911,083558.13-37.2
Net Cash Growth
-32.73%161.63%240.96%93.96%--
Net Cash Per Share
4.236.752.980.920.61-0.05
Filing Date Shares Outstanding
1,5511,5381,3931,2311,072832.92
Total Common Shares Outstanding
1,5511,5381,3931,2311,072832.92
Working Capital
6,5549,6533,6701,084565.646.6
Book Value Per Share
6.056.302.690.950.600.06
Tangible Book Value
9,3779,6973,7411,164644.6646.53
Tangible Book Value Per Share
6.056.302.690.950.600.06
Machinery
149.69138.75129.99121.55112.7676.42
Construction In Progress
--1.141.820.331.29
Source: S&P Global Market Intelligence. Standard template. Financial Sources.